A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men

References

• Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018. Atlanta: U.S. Department of Health and Human Services; 2019.
   Google Scholar
• World Health Organization. Report on Global Sexually Transmitted Infection Surveillance 2018. 2018.
   Google Scholar
• Rowley J, Hoorn SV, Korenromp E, et al. Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis: global Prevalence and Incidence Estimates, 2016. Geneva: Bulletin of the World Health Organization; 2019.
   Google Scholar
• Wi TE, Ndowa FJ, Ferreyra C, et al., Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forward. J Int AIDS Soc. 2019;22(S6): e25343.
   PubMed Web of Science ®Google Scholar
• Chesson HW, Kirkcaldy RD, Gift TL, et al. An illustration of the potential health and economic benefits of combating antibiotic-resistant gonorrhea. Sex Transm Dis. 2018;45(4):250.
   PubMed Web of Science ®Google Scholar
• LaMontagne DS, Fine DN, Marrazzo JM, et al. Chlamydia trachomatis infection in asymptomatic men. Am J Prev Med. 2003;24(1):36–42.
   PubMed Web of Science ®Google Scholar
• Lewis J, PJ W. Estimating local chlamydia incidence and prevalence using surveillance data. Epidemiol. 2017;28(4):492.
   PubMed Web of Science ®Google Scholar
• Herbst de Cortina S, Cc B, Joseph DD, et al. A systematic review of point of care testing for chlamydia trachomatis, neisseria gonorrhoeae, and trichomonas vaginalis. Infect Dis Obstet Gynecol. 2016;17:1–18.
   Google Scholar
• Gaydos C, Hardick J. Point of care diagnostics for sexually transmitted infections: perspectives and advances. Expert Rev Anti Infect Ther. 2014;12(6):657–672.
   PubMed Web of Science ®Google Scholar
• Papp J, Schachter J, Gaydos C, et al. Recommendations for the laboratory-based detection of chlamydia trachomatis and neisseria gonorrhoeae — 2014. MMWR. 2014;63(RR–2):1–24.
   PubMed Web of Science ®Google Scholar
• Cherkaoui A, Renzi G, Mombelli M, et al. Comparison of analytical performances of the roche cobas 6800 CT/NG assay with the abbott m2000 real time CT/NG assay for detecting chlamydia trachomatis and neisseria gonorrhoeae. J Med Microbiol. 2019;68(2):197–200.
   PubMed Web of Science ®Google Scholar
• Unemo M, Hansen M, Hadad R, et al. Sensitivity, specificity, inclusivity and exclusivity of the updated aptima combo 2 assay, which provides detection coverage of the new diagnostic-escape chlamydia trachomatis variants. BMC Infect Dis. 2020;20(1):1–6.
   Web of Science ®Google Scholar
• Van Der Pol B, Fife K, Taylor SN, et al. Evaluation of the performance of the cobas CT/NG test for use on the cobas 6800/8800 systems for detection of chlamydia trachomatis and neisseria gonorrhoeae in male and female urogenital samples. J Clin Microbiol. 2019;57(4):e01996–01918.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Hook EW 3rd, Williams JA, et al. Performance of the BD CTQX and GCQX amplified assays on the BD viper LT compared with the BD viper XTR system. Sex Transm Dis. 2015;42(9):521–523.
   PubMed Web of Science ®Google Scholar
• Nye MB, Osiecki J, Lewinski M, et al. Detection of chlamydia trachomatis and neisseria gonorrhoeae with the cobas CT/NG v2.0 test: performance compared with the BD probetec CT Q(X) and GC Q(X) amplified DNA and aptima AC2 assays. Sex Transm Infect. 2019;95(2):87–93.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Torres-Chavolla E, Kodsi S, et al. Clinical Performance of the BD CTGCTV2 assay for the BD max™ system for detection of chlamydia trachomatis, neisseria gonorrhoeae and trichomonas vaginalis infections. Sex Transm Dis. 2021; 48:134-140.
   Web of Science ®Google Scholar
• Van Der Pol B, Williams JA, Fuller D, et al. Combined testing for chlamydia, gonorrhea, and trichomonas by use of the BD MAX CT/GC/TV assay with genitourinary specimen types. J Clin Microbiol. 2017;55(1):155–164.
   PubMed Web of Science ®Google Scholar
• Bristow CC, Morris SR, Little SJ, et al. Meta-analysis of the cepheid xpert® CT/NG assay for extragenital detection of chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) infections. Sex Health. 2019;16(4):314–319.
   PubMed Web of Science ®Google Scholar
• Gaydos CA, Van Der Pol B, Jett-Goheen M, et al. Performance of the cepheid CT/NG xpert rapid PCR test for detection of chlamydia trachomatis and neisseria gonorrhoeae. J Clin Microbiol. 2013;51(6):1666–1672.
   PubMed Web of Science ®Google Scholar
• De Salazar A, Espadafor B, Fuentes-López A, et al. Comparison between aptima assays (hologic) and the allplex STI essential assay (seegene) for the diagnosis of sexually transmitted infections. PloS One. 2019;14(9):e0222439.
   PubMed Web of Science ®Google Scholar
• Mm R, Na M, Tl G, et al., Potential for point-of-care tests to reduce chlamydia-associated burden in the United States: a mathematical modeling analysis. Clin Infect Dis. 2020. ;70(9): 1816–1823.
   PubMed Web of Science ®Google Scholar
• Olson-Chen C, Balaram K, Hackney DN, et al. Chlamydia trachomatis and adverse pregnancy outcomes: meta-analysis of patients with and without infection. Matern Child Health J. 2018;22(6):812–821.
   PubMed Web of Science ®Google Scholar
• Arustamyan K, Totoyan E, Karapetyan A, et al. The State of fallopian tubes in women with urogenital chlamydia and infertility. Georgian Med News. 2017;80:268–269.
   Google Scholar
• Reekie J, Donovan B, Guy R, et al. Risk of ectopic pregnancy and tubal infertility following gonorrhea and chlamydia infections. Clin Infect Dis. 2019;69(9):1621–1623.
   PubMed Web of Science ®Google Scholar
• Buckner LR, Amedee AM, Albritton HL, et al. Chlamydia trachomatis infection of endocervical epithelial cells enhances early HIV transmission events. PLoS One. 2016;11(1):e0146663.
   PubMed Web of Science ®Google Scholar
• Dm P, Dp S, Holden J, et al. Evaluation of a novel electrochemical detection method for chlamydia trachomatis: application for point-of-care diagnostics. IEEE Trans Biomed Eng. 2010;58(3):755–758.
   PubMed Web of Science ®Google Scholar
• Trotter M, Borst N, Thewes R, et al. Electrochemical DNA sensing–principles, commercial systems, and applications. Biosens Bioelectron. 2020;154:112069.
   PubMed Web of Science ®Google Scholar
• Niemi S, Hiltunen-Back E, Puolakkainen M. et al. Chlamydia trachomatis genotypes and the Swedish new variant among urogenital chlamydia trachomatis strains in Finland. Infect Dis Obstet Gynecol. 2011; 2011.
   Google Scholar
• Huntington SE, Burns RM, Harding-Esch E, et al., Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees. BMJ Open. 2018. ;8(9): e020394.
   PubMed Web of Science ®Google Scholar
• Widdice LE, Hsieh Y-H, Silver B, et al. Performance of the atlas rapid test for chlamydia trachomatis and women’s attitudes toward point-of-care testing. Sex Transm Dis. 2018;45(11):723.
   PubMed Web of Science ®Google Scholar
• Em H-E, Av N, Hegazi A, et al., Impact of deploying multiple point-of-care tests with a ‘Sample First’ approach on a sexual health clinical care pathway. A service evaluation. Sex Transm Infect. 2017. ;93(6): 424–429.
   PubMed Web of Science ®Google Scholar
• Gettinger J, Van WN, Daniels B, et al., Patients are willing to wait for rapid sexually transmitted infection results in a University student health clinic. Sex Transm Dis. 2020. ;47(1): 67–69.
   PubMed Web of Science ®Google Scholar
• Gift T, Pate M, Hook E, et al. The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for hlamydia trachomatis. Sex Transm. Dis. 1999;26(4):232–240.
   PubMed Web of Science ®Google Scholar
• Harding-Esch EM, Cousins EC, Chow S-L, et al. A 30-min Nucleic Acid amplification point-of-care test for genital Chlamydia trachomatis infection in women: a prospective. Multi-Center Study of Diagnostic Accuracy. ebiomed. 2018;28:120–127.
   Google Scholar
• Van Der Pol B, Sn T, Mena L, et al., Evaluation of the performance of a point-of-care test for chlamydia and gonorrhea. JAMA Network Open. 2020 ;3(5): e204819–e204819.
   PubMed Web of Science ®Google Scholar
• Lm C, RJ G, Sn T, et al. Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation. Sex Transm Infect. 2018;94(5):340–345.
   PubMed Web of Science ®Google Scholar
• Wingrove I, McOwan A, Nwokolo N, et al. Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation. Sex Transm Infect. 2014;90(6):474.
   PubMed Web of Science ®Google Scholar
• Meyer T, Buder S. The laboratory diagnosis of neisseria gonorrhoeae: current testing and future demands. Pathog. 2020;9(2):91.
   Web of Science ®Google Scholar
• Mm M. The point-of-care diagnostic landscape for sexually transmitted infections (STIs).[cited 2020 Oct 20]. Available from: https://www.who.int/reproductivehealth/topics/rtis/Diagnostic-Landscape-for-STIs-2019.pdf.
   Google Scholar
• Bristow CC, Wierzbicki M, Sarno M, et al. Performance of a single use rapid point-of-care pcr device for the detection of neisseria gonorrhoeae, chlamydia trachomatis and trichomonas vaginalis. Sex Trans Dis. 2020;47(S2):S148.
   Google Scholar
• Morris SR, Bristow CC, Wierzbicki MR, et al. Performance of a single-use, rapid, point-of-care PCR device for the detection of neisseria gonorrhoeae, chlamydia trachomatis, and trichomonas vaginalis: a cross-sectional study. Lancet Infect Dis. 2020;5:668-676.
   Web of Science ®Google Scholar
• Van Der Pol B. Making the most of point-of-care testing for sexually transmitted diseases. Clin Infec Dis. 2019;70(9):1824–1825.
   Web of Science ®Google Scholar
• Fisk KM, Derouin A, Holm G, et al. Getting it right: the impact of point-of-care testing for gonorrhea and chlamydia in the urgent care setting. J Nurse Pract. 2020;16(5):388–393.
   Google Scholar
• Korte BJ, Rompalo A, Manabe YC, et al. Overcoming challenges with the adoption of point-of-care testing: from Technology push and clinical needs to value propositions. Point Care. 2020;19(3):77–83.
   PubMed Web of Science ®Google Scholar
• Pai NP, Vadnais C, Denkinger C, et al. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low-and middle-income Countries. PLoS Med. 2012;9(9):e1001306.
   PubMed Web of Science ®Google Scholar
• Stewart J, Bukusi E, Celum C, et al. Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention. AIDS. 2020;34(5):651–658.
   PubMed Web of Science ®Google Scholar